<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
60432-604-04
</NDCCode>
<PackageDescription>
118 mL in 1 BOTTLE, PLASTIC (60432-604-04)
</PackageDescription>
<NDC11Code>
60432-0604-04
</NDC11Code>
<ProductNDC>
60432-604
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Dextromethorphan Hydrobromide And Promethazine Hydrochloride
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Dextromethorphan Hydrobromide And Promethazine Hydrochloride
</NonProprietaryName>
<DosageFormName>
SYRUP
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
19850104
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA088864
</ApplicationNumber>
<LabelerName>
Morton Grove Pharmaceuticals, Inc.
</LabelerName>
<SubstanceName>
DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
15; 6.25
</StrengthNumber>
<StrengthUnit>
mg/5mL; mg/5mL
</StrengthUnit>
<Pharm_Classes>
Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],Sigma-1 Agonist [EPC],Uncompetitive NMDA Receptor Antagonists [MoA],Sigma-1 Receptor Agonists [MoA],Phenothiazine [EPC],Phenothiazines [Chemical/Ingredient]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2017-07-27
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>